Nexgard Spectra 37.5 mg (Afoxolaner TABLET (CHEWABLE)) 37.5 MG

NEXGARD SPECTRA 37.5 MG chewable tablets provide broad-spectrum parasite protection for dogs. This medication combines afoxolaner with other active ingredients to target fleas, ticks, and internal parasites. Ideal for pet owners seeking comprehensive parasite control.

Strength

37.5 MG

Pack Size

3/6/12

Manufacturer / TM Owner

BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

NEXGARD SPECTRA 37.5 MG chewable tablets are designed to protect dogs from various parasites, including fleas, ticks, and internal parasites. This medication is commonly used for what is NEXGARD SPECTRA used for, which includes preventing infestations and providing ongoing protection against common pests that can affect canine health.

Side Effects

When administered as directed, NEXGARD SPECTRA 37.5 MG chewable tablets work to eliminate and prevent infestations of fleas and ticks. The active ingredient, afoxolaner, targets these parasites, helping to maintain your dog's comfort and well-being. Some pets may experience mild effects, such as vomiting or diarrhea, after taking the medication.

Precautions & Warnings

Always follow the guidance of a veterinarian when administering NEXGARD SPECTRA 37.5 MG chewable tablets. Ensure the medication is stored in a cool, dry place away from children and other pets. Monitor your dog for any adverse reactions and consult a veterinarian if concerns arise.

Avoid Interactions

NEXGARD SPECTRA 37.5 MG chewable tablets may interact with other medications, so it's important to inform your veterinarian of any other treatments your dog is receiving. Avoid administering this medication with other flea and tick products unless directed by a professional.

Frequently Asked Questions

NEXGARD SPECTRA 37.5 MG chewable tablets are used to protect dogs from fleas, ticks, and internal parasites.

Administer the chewable tablet as directed by your veterinarian, typically given with food for better absorption.

Common side effects may include vomiting, diarrhea, lethargy, and decreased appetite.

Consult your veterinarian before using NEXGARD SPECTRA 37.5 MG with other medications to avoid potential interactions.

Store NEXGARD SPECTRA 37.5 MG chewable tablets in a cool, dry place away from children and other pets.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.